INTERNATIONAL FOOTPRINT
IHH's significant presence in so many growth markets distinguishes us from other healthcare operators worldwide.
Sri Lanka

Fortis Healthcare has an interest in Lanka Hospitals that operates in Sri Lanka.

Brunei

We own and operate the Gleneagles JPMC Cardiac Centre through a joint venture with Brunei Investment Agency

Bulgaria

In 2016, the group announced the acquisition of Tokuda Hospital and completed a merger with City Clinic in becoming the leading private healthcare operator in Bulgaria. With presence in the 3 largest cities of Bulgaria, Acibadem City Clinic combines 3 hospitals and 4 outpatient medical centres

Macedonia

Acibadem Holding's extensive network in the region includes Acibadem Sistina Hospital in Macedonia.

Netherlands
Acibadem International Medical Center opened its doors in Amsterdam, the capital city of the Netherlands on May 1, 2017. The Medical center was converted to a Hospital in 2019.
Turkey

Acibadem Holding (Acibadem) is Turkey's leading private healthcare provider, operating more than 4,000 beds across 21 hospitals and 13 medical clinics across Turkey, Macedonia, Bulgaria and the Netherlands. Acibadem operates 16 hospitals in Turkey and is known for high quality diagnostic services and clinical treatment offerings for Turkish and international patients.

India

India is our fourth home market with a network of 34 Hospitals and more than 5800 licensed beds. In 2015, the Group announced the acquisition of controlling stake in Continental Hospitals and Global Hospitals. The Group has since rebrand the hospitals under the Gleneagles Brand.

In 2018, the Group completed a preferential allotment of 31.17% stake in Fortis Healthcare making the Group its largest shareholder with board control. In addition, IHH also has a 50-50 joint venture with Apollo Hospitals Enterprise Ltd to operate Apollo Gleneagles Hospitals in Kolkata.

Malaysia

IHH is Malaysia's second largest private healthcare provider, based on number of licensed beds. Our hospital network operates under the Pantai and Gleneagles brands and has 16 hospitals with more than 2,500 licensed beds across Malaysia. To support our hospital network, we have ancillary healthcare services including, Pantai Integrated Rehab and Pantai Premier Pathology.

IHH also has an education arm, International Medical University (IMU) and International Medical College (IMC), which offers medical, pharmacy, nursing, dentistry, health science and complementary medicine programmes.

Singapore

IHH is Singapore's leading private healthcare provider and our brands – Mount Elizabeth, Gleneagles and Parkway – are synonymous with exceptional quality and prestige in healthcare services. We have four hospitals with close to 1,000 licensed beds and a network of more than 50 medical centres and clinics. Our one-stop continuum of care also includes ancillary services in the form of ParkwayHealth Laboratory, ParkwayHealth Radiology and Angsana Molecular & Diagnostics. Through Parkway College, we also operate an education arm for Nursing, Allied Health and Healthcare Management.

Greater China

In China, we operate Gleneagles Chengdu Hospital which recently opened in October 2019. We have seven ParkwayHealth Medical Centres under our auspices. In Hong Kong, we operate a multi-specialty Gleneagles Hospital Hong Kong, which opened in March 2017. Under our Greater China portfolio, we also operate the Gleneagles Medical Clinic Central, Hong Kong and the Angsana Molecular and Diagnostics ancillary service.

  • Home Markets
  • Key Growth Markets
  • Other International Markets
As at 31 December 2019
Source Date: 30 March 2020